ABHD2
Monoacylglycerol lipase ABHD2
Also known as: ABHD2_HUMAN, LABH2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08910
- Gene
- ABHD2
- Ensembl
- ENSG00000140526
- Chromosome
- 15
- Canonical length
- 425 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol,Connecting piece,Flagellar centriole
OverviewNCBI Gene
This gene encodes a protein containing an alpha/beta hydrolase fold, which is a catalytic domain found in a wide range of enzymes. The encoded protein is an acylglycerol lipase that catalyzes the hydrolysis of endocannabinoid arachidonoylglycerol from the cell membrane. This leads to activation of the sperm calcium channel CatSper, which results in sperm activation. Alternative splicing of this gene results in two transcript variants encoding the same protein. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
425 residues, UniProt reviewed canonical sequence.
>P08910|ABHD2
1 MNAMLETPEL PAVFDGVKLA AVAAVLYVIV RCLNLKSPTA PPDLYFQDSG LSRFLLKSCP
61 LLTKEYIPPL IWGKSGHIQT ALYGKMGRVR SPHPYGHRKF ITMSDGATST FDLFEPLAEH
121 CVGDDITMVI CPGIANHSEK QYIRTFVDYA QKNGYRCAVL NHLGALPNIE LTSPRMFTYG
181 CTWEFGAMVN YIKKTYPLTQ LVVVGFSLGG NIVCKYLGET QANQEKVLCC VSVCQGYSAL
241 RAQETFMQWD QCRRFYNFLM ADNMKKIILS HRQALFGDHV KKPQSLEDTD LSRLYTATSL
301 MQIDDNVMRK FHGYNSLKEY YEEESCMRYL HRIYVPLMLV NAADDPLVHE SLLTIPKSLS
361 EKRENVMFVL PLHGGHLGFF EGSVLFPEPL TWMDKLVVEY ANAICQWERN KLQCSDTEQV
421 EADLELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 129 nTPM
Expression across tissuesHPA
Tissue
- liver: 129 nTPM
- stomach: 69 nTPM
- choroid plexus: 65 nTPM
- pancreas: 55 nTPM
- epididymis: 53 nTPM
- testis: 49 nTPM
Single-cell type
- neutrophils: 908 nCPM
- late spermatids: 806 nCPM
- hepatocytes: 692 nCPM
- foveolar cells: 670 nCPM
- oligodendrocyte progenitor cells: 642 nCPM
- epididymal principal cells: 464 nCPM
Immune cell
- eosinophil: 70 nTPM
- neutrophil: 53 nTPM
- non-classical monocyte: 18 nTPM
- classical monocyte: 14 nTPM
- intermediate monocyte: 11 nTPM
- NK-cell: 11 nTPM
Brain region
- choroid plexus: 328 nTPM
- cerebellum: 134 nTPM
- midbrain: 123 nTPM
- hippocampal formation: 112 nTPM
- cerebral cortex: 107 nTPM
- thalamus: 105 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.68
- gnomAD missense Z
- 2.23
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acrosome reaction
- acylglycerol catabolic process
- medium-chain fatty acid biosynthetic process
- medium-chain fatty acid catabolic process
- negative regulation of smooth muscle cell migration
- response to progesterone
- response to wounding
- smooth muscle cell migration
- sperm capacitation
- steroid hormone receptor signaling pathway
Molecular functions
- acetylesterase activity
- diacylglycerol lipase activity
- hormone binding
- monoacylglycerol lipase activity
- nuclear steroid receptor activity
- triacylglycerol lipase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD2 as an antibody target. Whether an autoantibody or antibody against ABHD2 could matter depends on whether native ABHD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD2 is annotated at the cell surface, where native ABHD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ABHD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...